GAL - galanin and GMAP prepropeptide Gene

Also Known as ETL8; GALN; GLNN; GMAP; GAL-GMAP

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 51083

About GAL

Cytogenetic location: 11q13.2 Genomic coordinates (GRCh38): 11:68,684,544-68,691,175 (from NCBI)

This gene has 2 transcripts (splice variants), 187 orthologues and is associated with 1 phenotype. Biased expression in appendix (RPKM 6.0), colon (RPKM 2.3) and 5 other tissues.

Summary

This gene encodes a neuroendocrine peptide that is widely expressed in the central and peripheral nervous systems and also the gastrointestinal tract, pancreas, adrenal gland and urogenital tract. The encoded protein is a precursor that is proteolytically processed to generate two mature peptides: Galanin and Galanin message-associated peptide (GMAP). Galanin has diverse physiological functions including nociception, feeding and energy homeostasis, osmotic regulation and water balance. GMAP has been demonstrated to possess Antifungal activity and hypothesized to be part of the innate immune system. [provided by RefSeq, Jul 2015]

GAL Products (1)

mRNA	Protein	Name
NM_015973.5	NP_057057.2	galanin peptides preproprotein

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables galanin receptor activity	IMP IMP: Inferred from mutant phenotype	25691535	GOA
enables neuropeptide hormone activity	IDA IDA: Inferred from direct assay	24517231	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	23597562	GOA
enables type 1 galanin receptor binding	IDA IDA: Inferred from direct assay	24517231	GOA
enables type 2 galanin receptor binding	IDA IDA: Inferred from direct assay	24517231	GOA
enables type 3 galanin receptor binding	IDA IDA: Inferred from direct assay	24517231	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in cAMP-mediated signaling	IDA IDA: Inferred from direct assay	17982695	GOA
involved in positive regulation of cortisol secretion	IDA IDA: Inferred from direct assay	17982695	GOA
involved in positive regulation of large conductance calcium-activated potassium channel activity	IDA IDA: Inferred from direct assay	24602615	GOA
involved in positive regulation of timing of catagen	IDA IDA: Inferred from direct assay	22329353	GOA
involved in positive regulation of transcription by RNA polymerase II	IDA IDA: Inferred from direct assay	24517231	GOA
involved in protein kinase A signaling	IDA IDA: Inferred from direct assay	17982695	GOA

Cellular Component GO Annotation	Evidence	References	Source
located in extracellular space	IDA IDA: Inferred from direct assay	9402244	GOA
located in neuronal cell body	IDA IDA: Inferred from direct assay	23415787	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

GAL Protein Structure

Galanin

GMAP

0
100
123 a.a.

Protein Preferred Names	Protein Names
galanin peptides	galanin prepropeptide

GAL Protein-protein interaction Information

Type	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	References
Intra	GAL	P22466	ASPH	Homo sapiens	Q12797-6	Validated Y2H	32296183
Intra	GAL	P22466	SGTA	Homo sapiens	O43765	Y2H Prey Pooling	32296183
Intra	GAL	P22466	SGTA	Homo sapiens	O43765	Y2H Array	32296183
Intra	GAL	P22466	SGTA	Homo sapiens	O43765	Y2H Prey Pooling	25416956
Intra	GAL	P22466	UBQLN1	Homo sapiens	Q9UMX0	Validated Y2H	32296183
Intra	GAL	P22466	UBQLN1	Homo sapiens	Q9UMX0	Y2H Array	32296183
Intra	GAL	P22466	UBQLN1	Homo sapiens	Q9UMX0	Y2H Prey Pooling	32296183
Intra	GAL	P22466	UBQLN2	Homo sapiens	Q9UHD9	Validated Y2H	32296183
Intra	GAL	P22466	UBQLN2	Homo sapiens	Q9UHD9	Y2H Array	32296183
Intra	GAL	P22466	UBQLN2	Homo sapiens	Q9UHD9	Y2H Prey Pooling	32296183

Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant GAL Proteins

Cat. No.	Product Name	Accession	Purity
HY-P74132	Galanin Protein, Human (HEK293, Fc)	P22466 (A20-S123)	≥ 95%, as determined by reducing SDS-PAGE.
HY-P700564	Galanin Protein, Human (N-His, C-Myc)	P22466 (G44-S123)	≥ 90%, as determined by reducing SDS-PAGE.

GAL Antibodies

Cat. No.	Product Name	Application	Reactivity
HY-P89540	Galanin Antibody (YA8884)	WB, ICC/IF, IF-Tissue, IHC-P, IP, ELISA	human

Related Diseases

Diseases	Alias
Epilepsy, Familial Temporal Lobe, 8	ETL8 Familial Temporal Lobe Epilepsy 8 Epilepsy, Temporal Lobe, Familial, Type 8
Acute Endometritis
Hyperprolactinemia	Chiari-Frommel Syndrome Hyperprolactinaemia Familial Hyperprolactinemia HPRL Pregnancy-Related A-G Syndrome Familial Isolated Prolactin Receptor Deficiency
Acromegaly	Gigantism Growth Hormone Excess Pituitary Giant Somatotroph Adenoma Growth Hormone-Secreting Pituitary Adenoma
Anorexia Nervosa	Anorexia Nervosa, Susceptibility To ANON Anorexia Nervosa, Susceptibility To, 1 An Anorexia Nervosa 1 An - [Anorexia Nervosa]
Status Epilepticus	Grand Mal Status Epilepticus Grand Mal Status Gcse Generalized Convulsive Status Epilepticus Se Epilepsy With Status Epilepticus
Paine Syndrome	Pain Disorder Pain Microcephaly With Spastic Diplegia Pain Syndrome
Epilepsy	Epilepsy Syndrome Epileptic Syndrome Epilepsies Symptomatic Epilepsies Post Traumatic Epilepsy Traumatic Epilepsy Traumatic Epileptic Epilepsy Due To Hippocampal Sclerosis Epilepsy With Ammon'S Horn Sclerosis Epilepsy Due To Cortical Dysplasia Epilepsy Due To Neuronal Migration Disorders
Insulinoma	Islet Cell Adenoma Insulin-Producing Tumor Of Islet Cells Adenoma Islet Cell Islet Cell Tumor Experimental Organism Islet Cell Adenoma Neoplasm
Anxiety	Anxiety Disorder Anxiety Disorders Anxiety State Anxieties Anxiety Neurosis
Autonomic Peripheral Neuropathy	Peripheral Autonomic Nervous System Diseases
Von Economo'S Disease	Encephalitis Lethargica Von Economo Encephalitis Von Economo Disease
Cholera	Vibrio Cholerae Infection Cholera - Vibrio Cholerae Cholera Due To Vibrio Cholerae Vibrio Cholerae Cholera Syndrome Asiatic Cholera Epidemic Cholera
Paraganglioma	Chemodectoma Glomus Body Tumor Paragangliomas Carotid Body Paraganglioma Extra-Adrenal Paraganglioma
Hyperthyroidism	Overactive Thyroid
Constipation
Hypoglycemia	Hypoglycaemia Low Blood Sugar Hypoglycaemia Nos Spontaneous Hypoglycaemia Nondiabetic Hypoglycaemia Hypoglycaemic Disorder Nos Hypoglycaemic Syndrome
Esophageal Atresia	Tracheoesophageal Fistula Congenital Atresia Of Esophagus Congenital Imperforate Esophagus Imperforate Esophagus Oesophageal Atresia Te Fistula Tef Tracheoesophageal Fistula With Or Without Esophageal Atresia
Panic Disorder	Panic Anxiety Syndrome Panic Panic Disorder 1 Episodic Paroxysmal Anxiety Disorder
Gastroenteritis	Cholera Morbus Infectious Colitis, Enteritis And Gastroenteritis Enteritis Due To Astrovirus Rotaviral Gastroenteritis Viral Gastroenteritis Due To Rotavirus
Alcohol Use Disorder	Alcohol Abuse Alcoholism Ethanol Abuse Alcohol Addiction Alcohol Dependence Alcoholic Intoxication, Chronic Alcohol-Related Disorders
Brachial Plexus Lesion	Brachial Plexus Injuries Brachial Plexus Lesions
Trophoblastic Neoplasm	Trophoblastic Tumor Trophoblastic Neoplasms
Mononeuropathy	Mononeuropathies
Eating Disorder	Eating Disorders Feeding And Eating Disorders
Complex Partial Epilepsy	Epilepsy, Complex Partial Complex Partial Epileptic Seizure Epilepsy, Psychomotor Psychomotor Epilepsy
Mood Disorder	Mood Disorders Episodic Mood Disorder
Alzheimer Disease, Familial, 1	Alzheimer Disease Alzheimer'S Disease Presenile And Senile Dementia AD1 Alzheimer Disease, Susceptibility To Alzheimer Disease, Late-Onset, Susceptibility To Alzheimer Disease 1, Familial AD Familial Alzheimer Disease Alzheimer Disease, Late-Onset Alzheimers Dementia Alzheimer Dementia Alzheimer Sclerosis Alzheimer Syndrome Alzheimer-Type Dementia Dat Primary Senile Degenerative Dementia Sdat Alzheimer Disease 1 Autosomal Dominant Alzheimer Disease Early-Onset Alzheimer Disease With Cerebral Amyloid Angiopathy Late Onset Alzheimer Disease Alzheimers Disease Alzheimer Disease, Early-Onset, With Cerebral Amyloid Angiopathy Late-Onset Alzheimers Disease Alzheimer'S Disease Pathway Kegg Dementia Due To Alzheimer'S Disease Alzheimer Disease Type 1 Alzheimers
Type 2 Diabetes Mellitus	Insulin Resistance NIDDM Type 2 Diabetes Diabetes Mellitus, Non-Insulin-Dependent T2D Noninsulin-Dependent Diabetes Mellitus Diabetes Mellitus, Type Ii Maturity-Onset Diabetes Insulin Resistance, Severe, Digenic Diabetes Mellitus, Type 2 Diabetes Mellitus, Noninsulin-Dependent Diabetes Mellitus, Noninsulin-Dependent, Association With Diabetes Mellitus, Noninsulin-Dependent, Late Onset Hypertension, Insulin Resistance-Related, Susceptibility To Insulin Resistance, Susceptibility To Non-Insulin-Dependent Diabetes Mellitus Type Ii Diabetes Mellitus Adult-Onset Diabetes Mellitus Maturity-Onset Diabetes Mellitus Diabetes Mellitus Type 2 Type Ii Diabetes Type 2 Diabetes Mellitus, Susceptibility To Diabetes, Type 2 Diabetes Mellitus, Noninsulin-Dependent, Susceptibility To Diabetes Mellitus, Non-Insulin-Dependent, Susceptibility To Diabetes Mellitus, Type 2, Susceptibility To Diabetes Mellitus, Noninsulin-Dependent, 2 Diabetes Mellitus, Type Ii, Susceptibility To Hypertension, Insulin Resistance-Related Adult-Onset Diabetes Aodm Diabetes Mellitus, Adult-Onset Diabetes Mellitus Type Ii Diabetes Mellitus Type 2, Susceptibility To Diabetes, Type Ii, Susceptibility To Diabetes Type 2 Diabetes Mellitus Adult Onset Diabetes Maturity Onset Diabetes Nonketotic Diabetes Non-Insulin Dependent Diabetes Mellitus T2dm - [Type 2 Diabetes Mellitus] Niddm - [Non Insulin Dependent Diabetes Mellitus] Dm2 Dm Type Ii Diabetic Type 2 Insulin Requiring Type 2 Diabetes Noninsulin Dependent Diabetes Non-Insulin-Dependent Diabetes Mellitus Without Complications Diabetes Due To Insulin Secretory Defect Diabetes Mellitus Due To Insulin Secretory Defect Non-Insulin-Dependent Diabetes Of The Young Senile Diabetes Nonketotic Hyperglycaemia Stable Diabetes
Major Depressive Disorder	Seasonal Affective Disorder Unipolar Depression Depression MDD Depressive Disorder Unipolar Depression, Susceptibility To Major Depressive Disorder 1 Major Depressive Disorder, Response To Citalopram Therapy In Major Depressive Disorder 2 Winter Depression Single Major Depressive Episode Sad Clinical Depression Major Depression Depressive Syndrome Major Depressive Disorder And Accelerated Response To Antidepressant Drug Treatment Seasonal Affective Disorder, Susceptibility To Recurrent Major Depression Affective Disorder, Seasonal Depression In A Seasonal Pattern Depression Seasonal Major Depressive Disorder With A Seasonal Pattern Seasonal Depression Seasonal Mood Disorder Mental Depression Recurrent Major Depressive Episodes
Autism Spectrum Disorder	Asd Autism Spectrum Disorders Autistic Continuum Pervasive Developmental Disorder Pervasive Development Disorder Autistic Behavior Autistic Disorder Autistic Autistic Disorder Of Childhood Onset Infantile Autism Childhood Autism Kanner Syndrome Pervasive Developmental Delay Nos Pervasive Developmental Disorder, Not Otherwise Specified
Body Mass Index Quantitative Trait Locus 11	OBESITY Obesity, Susceptibility To Leanness, Inherited Obesity, Susceptibility To, Bmiq11 Obesity, Mild, Early-Onset Obesity, Association With Obesity, Early-Onset, Susceptibility To Obesity, Severe Obesity, Severe, And Type Ii Diabetes Obesity, Late-Onset Obesity , Susceptibility To BMIQ11 Obesity Bmiq11 Obesity, Early-Onset Simple Obesity Nos Excess Fat Obesity, Not Elsewhere Classified, Body Mass Index Not Elsewhere Classified Adiposis
Alcohol Dependence	Alcoholism Alcohol Dependence, Susceptibility To Alcohol Dependence, Protection Against Aerodigestive Tract Cancer, Squamous Cell, Alcohol-Related, Protection Against Alcoholism, Susceptibility To Alcoholic Intoxication, Chronic Pharyngeal Neoplasms Chronic Alcoholism Dipsomania Alcohol Addiction Ethanol Dependence Chronic Ethanolism Chronic Alcoholic Disease Nos Alcoholic Disease Nos Alcoholic
Diabetes Mellitus	Diabetes
Autism	Autistic Disorder Autism Susceptibility 1 Childhood Autism Autistic Disorder Of Childhood Onset Infantile Autism Kanner'S Syndrome Autistic
Congenital Central Hypoventilation Syndrome	Cchs Haddad Syndrome Ondine Curse Ondine Syndrome Congenital Central Hypoventilation Congenital Central Alveolar Hypoventilation Syndrome Congenital Failure Of Autonomic Control Ondine'S Curse Primary Alveolar Hypoventilation Ondine-Hirschsprung Disease Central Congenital Hypoventilation Syndrome Congenital Ondine Curse Idiopathic Congenital Central Alveolar Hypoventilation Congenital Central Alveolar Hypoventilation-Hirschsprung Disease Syndrome Ondine-Hirschsprung Syndrome
Hirschsprung Disease 1	Hirschsprung Disease Aganglionic Megacolon Hscr Hirschsprung'S Disease Congenital Megacolon Congenital Intestinal Aganglionosis Colonic Aganglionosis Hirschsprung Disease, Susceptibility To, 1 Hirschsprung Disease, Protection Against HSCR1 Mgc Pelvirectal Achalasia Total Intestinal Aganglionosis Megacolon, Aganglionic Macrocolon Hscr 1 Hirschsprung Disease Type 1 Hirschsprung Disease, Type 1 Congenital Dilatation Of Colon Aganglionosis Congenital Aganglionic Megacolon Aganglionosis Of Colon Bowel Aganglionosis Colon Aganglionosis Hirschsprung Megacolon

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (2)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-14929A	Migalastat hydrochloride	Inhibitor	99.70%	Yes
HY-14929	Migalastat	Inhibitor	/	Unkown

Clinical Phase

Bioactive Molecules (9)

Cat. No.	Product Name	Effect	Purity	Phase
HY-114440	Belapectin		98.94%	Phase 3
HY-W013053	Dibenz[a,h]anthracene	Inducer	98.0%	Phase 3
HY-100717	HT-2157	Antagonist	98.0%	Phase 2
HY-E70052	alpha-1,3-Galactosyltransferase (a1,3GalT)		/	Phase 2
HY-136527	BMS-986251		/	Phase 2
HY-156996	AGI-134		/	Phase 2
HY-100443	PX20606	Agonist	/	Phase 1
HY-139562	BMS-986318	Agonist	/	Phase 1
HY-158460	Alpha-Gal		/	Phase 1

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P991396	LY-3321367	Inhibitor	99.0%	Phase 1

Pre-clinical Phase

Bioactive Molecules (161)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-114409	GB1107	Inhibitor	99.92%	Unkown
HY-15934	X-GAL		99.88%	Unkown
HY-130208	Thiodigalactoside	Inhibitor	99.95%	Unkown
HY-137276	5-Bromo-3-indolyl β-D-galactopyranoside	Substrate	99.89%	Unkown
HY-P2869	β-Galactosidase, E. coli		/	Unkown
HY-114522	X-alpha-Gal		99.87%	Unkown
HY-118135	4-Methylumbelliferyl-α-D-galactopyranoside		99.96%	Unkown
HY-155175	TIM-3-IN-2		99.44%	Unkown
HY-158742	SBB-Analogue (GL13) Biotin		99.30%	Unkown
HY-173496	ST6GAL1-IN-1	Inhibitor	99.33%	Unkown
HY-P1723	Spexin		99.12%	Unkown
HY-NP0182	Peanut Agglutinin (Biotinylated)		/	Unkown
HY-P1135	M1145	Agonist	99.96%	Unkown
HY-123148	IMB-808	Agonist	99.84%	Unkown
HY-DY2002	X-GAL (solution)		/	Unkown
HY-P1131	M617	Agonist	99.54%	Unkown
HY-P1132A	Galanin (1-29)(rat, mouse) TFA	Agonist	99.70%	Unkown
HY-101422	GAL-021	Inhibitor	99.93%	Unkown
HY-104004	Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH		99.12%	Unkown
HY-NP0138	Peanut Agglutinin (Fluorescein)		/	Unkown
HY-P3443	Peanut agglutinin		/	Unkown
HY-103536A	Galnon TFA	Agonist	98.88%	Unkown
HY-P0232	Fmoc-Thr[GalNAc(Ac)3-α-D]-OH		99.08%	Unkown
HY-P1765	Galanin (1-19), human		99.25%	Unkown
HY-W127769	Rose-β-D-Gal		99.71%	Unkown
HY-W145561	Neu5Acα(2-3)Galβ MP glycoside		99.84%	Unkown
HY-10678	BMS-687453	Agonist	99.31%	Unkown
HY-146808	Galectin-3 antagonist 1	Antagonist	98.95%	Unkown
HY-133737	GAL-02-221	Inhibitor	99.87%	Unkown
HY-141488	Lacto-N-biose I		98.0%	Unkown
HY-W039911	4-Nitrophenyl α-D-galactopyranoside		98.70%	Unkown
HY-E70136	Endo-β-Galactosidase		/	Unkown
HY-P0262A	Galantide TFA	Antagonist	98.77%	Unkown
HY-185060	N-Acetyllactosamine-C2-NH2		/	Unkown
HY-RS29497	GAL3ST2 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-170510	GB2095	Inhibitor	98.92%	Unkown
HY-E70061	alpha-1,3-N-Acetylgalactosaminyltransferase (BgtA)		/	Unkown
HY-144312	Thiobis-β-Galactose-propyne	Inhibitor	99.76%	Unkown
HY-153823	UDP-6N3Gal		96.57%	Unkown
HY-105327	P11149	Inhibitor	99.23%	Unkown
HY-132239	5-Bromo-6-chloro-3-indolyl β-D-Galactopyranoside contains ca. 10% Ethyl Acetate		99.58%	Unkown
HY-135378	Atorvastatin ethyl ester		98.16%	Unkown
HY-147041A	(2S)-Selvigaltin	Inhibitor	99.46%	Unkown
HY-160694	cBu-Cit-GAL-02-221	Degrader	/	Unkown
HY-163548	SPP-002	Inhibitor	98.0%	Unkown
HY-180467	Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me		/	Unkown
HY-180467A	Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me sodium		/	Unkown
HY-E70033	D-galactosyl-β1-3-N-acetyl-D-hexosamine phosphorylase (BiGalHexNAcP)		/	Unkown
HY-P10010	DB21, Galectin-1 Antagonist	Inhibitor	/	Unkown
HY-P1128	Galanin (swine)	Agonist	98.75%	Unkown
HY-P1131A	M617 TFA		99.38%	Unkown
HY-RS13851	ST3GAL6 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS17282	St6gal1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W415856	β-D-galactose		/	Unkown
HY-101422A	GAL-021 sulfate	Inhibitor	/	Unkown
HY-103536	Galnon	Agonist	/	Unkown
HY-111366	CD12681	Agonist	/	Unkown
HY-112752	Gal-C4-Chol		/	Unkown
HY-121542	PPARδ agonist 10	Agonist	/	Unkown
HY-123708	SNAP 398299	Antagonist	/	Unkown
HY-130570	β-Gal-NONOate	Inhibitor	/	Unkown
HY-144313	Galectin-3-IN-2	Inhibitor	/	Unkown
HY-147112	MNP-GAL		/	Unkown
HY-147209	DC-TEAD3in03	Inhibitor	/	Unkown
HY-147865	Apoptosis inducer 8		/	Unkown
HY-14929S	Migalastat-d2 hydrochloride	Inhibitor	/	Unkown
HY-151514	Antituberculosis agent-5	Inhibitor	99.76%	Unkown
HY-156232	Gal-GIcNAc-oxazoline		/	Unkown
HY-158331	Gal-ARV-771		/	Unkown
HY-158461	Alpha-Gal standard, 2-AA labelled		/	Unkown
HY-158462	Alpha-Gal standard, 2-AB labelled		/	Unkown
HY-163078	C2-Gal-Dox		/	Unkown
HY-163405	Galectin-3-IN-3	Inhibitor	/	Unkown
HY-165424	NIR-BG2	Substrate	/	Unkown
HY-169084	ST-IN-1	Inhibitor	/	Unkown
HY-172888	SPP-037	Inhibitor	/	Unkown
HY-173235	Galectin-3-IN-6	Inhibitor	/	Unkown
HY-175490	RORγ inverse agonist 2	Antagonist	/	Unkown
HY-177945	MS99-β-Gal	Degrader	/	Unkown
HY-179101	IAN-15B	Inhibitor	/	Unkown
HY-179410	Galectin-3-IN-7	Inhibitor	/	Unkown
HY-181648	Gal-1-IN-1	Inhibitor	/	Unkown
HY-182898	Gal-dMor-Gem	Inducer	/	Unkown
HY-D1510	4-Nitrophenyl 2-O-(β-L-Fucopyranosyl)-β-D-Galactopyranoside		/	Unkown
HY-D2990	KSA01		/	Unkown
HY-D2992	KSA02		/	Unkown
HY-D3096	TPh–PyBz–β–gal		/	Unkown
HY-D3165	DCM-gal-CF		/	Unkown
HY-E70053	alpha-1,3-Galactosyltransferase (GTB)		/	Unkown
HY-E70169	Galactose-3-O-sulfotransferase 2		/	Unkown
HY-E70298	ST3 β-Gal α-2,3-Sialyltransferase 1		/	Unkown
HY-E70299	ST3 β-Gal α-2,3-Sialyltransferase 5	Inhibitor	/	Unkown
HY-E70995	Galactose-1-phosphate Uridyltransferase, Galactose-adapted yeast		/	Unkown
HY-E71300	β-Galactoside α-2,3-sialyltransferase		/	Unkown
HY-N10527	Isoglobotetraose		/	Unkown
HY-N12016	Fulvotomentoside B		/	Unkown
HY-N9134	5-O-Methylgenistein	Inhibitor	/	Unkown
HY-NP085	Griffonia Simplicifolia Lectin I Isolectin B4		/	Unkown
HY-P1128A	Galanin (swine) TFA	Agonist	/	Unkown
HY-P1132	Galanin (1-29)(rat, mouse)	Agonist	/	Unkown
HY-P1133	Galanin (2-29) (rat)	Agonist	/	Unkown
HY-P1135A	M1145 TFA	Agonist	/	Unkown
HY-P1560	Allergen Gal d 4 (46-61), chicken	Inhibitor	/	Unkown
HY-P1723A	Spexin TFA		/	Unkown
HY-P5896	Ala5-Galanin (2-11)	Agonist	/	Unkown
HY-RS05238	GAL Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS05239	GAL3ST1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS05240	GAL3ST4 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS05263	GALP Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS13846	ST3GAL1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS13847	ST3GAL2 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS13848	ST3GAL3 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS13849	ST3GAL4 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS13850	ST3GAL5 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS13852	ST6GAL1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS13853	ST6GAL2 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W145524	Gal[246Bn,3All]-β-SPh		/	Unkown
HY-W145538	Nonasaccharide Glc4Xyl3Gal2		/	Unkown
HY-W145540	Galβ(1-3)[Neu5Acα(2-6)]GalNAc-α-pNP		/	Unkown
HY-W145556	Galβ(1-3)GlcNAcβ(1-3)Galβ(1-4)Glc-β-pNP		/	Unkown
HY-W145558	Galβ(1-4)Glc-β-MP		/	Unkown
HY-W145559	Gal[236Bn]β(1-4)Glc[236Bn]-β-MP		/	Unkown
HY-W145594	Gal[26Bn]β(1-4)Glc[236Bn]-β-MP		/	Unkown
HY-W145607	Galβ(1-3)GalNAc-β-pNP		/	Unkown
HY-W145609	Neu5Troc[1Me,4789Ac]α(2-3)Gal[26Bn]-β-MP		/	Unkown
HY-W145620	Gal[246Bn]β(1-4)Glc[236Bn]-β-MP		/	Unkown
HY-W145621	Gal[2346Bn]-β-SPh		/	Unkown
HY-W145622	Galβ(1-3)[Neu5Acα(2-6)]GlcNAc-β-pNP		/	Unkown
HY-W145655	Gal-β1,3-GalNAc-α1-OBn		/	Unkown
HY-W145663	Gal-β1,3-GalNAc-β-OMe		/	Unkown
HY-W154295	Purple-β-D-Gal		/	Unkown
HY-W357147	4-Trifluoromethylumbelliferyl-ß-D-galactopyranoside		/	Unkown
HY-W357155	Gal1-β-3GlcNAc-β-PNP		/	Unkown
HY-W393498	Phenyl 2,4,6-tri-O-acetyl-3-O-allyl-β-D-thiogalactopyranoside		/	Unkown
HY-W698354	Gal1-β-3GlcNAc1-β-Ome		/	Unkown
HY-W698379	Gal1-b-4GlcNAc-α-PNP		/	Unkown
HY-W698547	2-(Acetylamino)-2-deoxy-3-O-α-D-galactopyranosyl-D-galactose		/	Unkown
HY-W698908	GalNAc1-b-3Gal-α-Ome		/	Unkown
HY-W699164	Gal1-β-4GlcNAc-β-Bn		/	Unkown
HY-W699180	Fuc1-α-2Gal1-β-3GlcNAc-β-PNP		/	Unkown
HY-W706304	Gal1-β-4GlcNAc1-β-6Gal		/	Unkown
HY-W740650	Migalastat hydrochloride-15N		/	Unkown
HY-104004R	Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH (Standard)		/	Unkown
HY-124445	APC0576	Inhibitor	/	Unkown
HY-135376	Atorvastatin methyl ester		98.76%	Unkown
HY-153101	Gal-G2-CNP		/	Unkown
HY-162789	Galectin-3-IN-5	Inhibitor	/	Unkown
HY-186237	Fuc(1→2)-Gal(3→1)(C3-amide-C5-biotin)-GalNAc		/	Unkown
HY-RS17286	Gal Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS18209	St3gal4 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS18441	St3gal3 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS19435	Ggta1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS20651	St3gal1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS20652	St6gal2 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS23737	St6gal1 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS23741	Gal Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS24686	St3gal4 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS24923	St3gal3 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS27162	St3gal1 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS27163	St6gal2 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W728096	Migalastat-d5	Inhibitor	/	Unkown

Inhibitory Antibodies (3)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P991198	M6903	Ligand	98.81%	Unkown
HY-P991369	EBU-141	Inhibitor	/	Unkown
HY-P992454	S095018	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Mus musculus	GAL	MGD	MGI:95637
Rattus norvegicus	GAL	RGD	RGD:61954
Bos taurus	GAL	VGNC	VGNC:29212
Macaca mulatta	GAL	VGNC	VGNC:72866
Felis catus	GAL	VGNC	VGNC:62435
Canis familiaris	GAL	VGNC	VGNC:41075
Others	GAL	NCBI